Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis

British Journal of Dermatology

Volumn 153, Issue 1, 2005, Pages 203-205

  Brown, M ^a   Noursadeghi, M ^d   Boyle, J ^b   Davidson, R N ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d NONE

Author keywords

Cutaneous leishmaniasis; Leishmania (vianna) braziliensis; Liposomal amphotericin

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY;

ADULT; ANAMNESIS; ARTICLE; BELIZE; CASE REPORT; CLINICAL FEATURE; DRUG TOLERABILITY; FEMALE; HOSPITAL PATIENT; HUMAN; LEISHMANIA BRAZILIENSIS; OUTPATIENT; PRIORITY JOURNAL; SKIN LEISHMANIASIS; SYSTEMIC THERAPY; VISCERAL LEISHMANIASIS;

ADULT; AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; HUMANS; LEG DERMATOSES; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; LIPOSOMES; MALE;

EID: 22944470218     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06670.x     Document Type: Article

References (16)

1. Jones T, Johnson WJ, Barretto A et al. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 1987; 156:73-83.
2. Berman J. Treatment of New World cutaneous and mucosal leishmaniasis. Clin Dermatol 1996; 14:519-22.
3. Berman J. Current treatment approaches to leishmaniasis. Curr Opin Infect Dis 2003; 16:397-401.
4. Aronson N, Wortmann G, Johnson S et al. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis 1998; 27:1457-64.
5. Soto J, Grogl M, Berman J et al. Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1994; 88:695-8.
6. Soto J, Buffet P, Grogl M et al. Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine. Am J Trop Med Hyg 1994; 50:107-11.
7. de Paula C, Sampaio J, Cardoso D et al. Estudo comparativo da eficácia de isotionato de pentamidina administrada em três doses durante uma semana e de N-metil-glucamina 20mgSbVAg/dia durante 20 dias para o tratamenio da forma cutânea da leishmaniose tegumentar americana. Rev Soc Bras Med Trop 2003; 36:365-71.
8. Velez I, Agudelo S, Hendrickx E et al. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Ann Intern Med 1997; 126:232-6.
9. Soto J, Arana B, Toledo J et al. Miltefosine for New World cutaneous leishmaniasis. Clin Infect Dis 2004; 38:1266-72.
10. Crofts M. Use of amphotericin B in mucocutaneous leishmaniasis. J Trop Med Hyg 1976; 79:111-3.
11. Yardley V, Croft S. Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis. Antimicrob Agents Chemother 1997; 41:752-6.
12. Amato V, Nicodemo A, Amato J et al. Mucocutaneous leishmaniasis associated with HIV infection treated successfully with liposomal amphotericin B (AmBisome). J Antimicrob Chemother 2000; 46:341-2.
13. Lawn S, Yardley V, Vega-Lopez F et al. New World cutaneous leishmaniasis in returned travellers: treatment failures using intravenous sodium stibogluconate. Trans R Soc Trop Med Hyg 2003; 97:443-5.
14. Rapp C, Imbert P, Darie H et al. Traitement par amphotéricine B liposomale d'une leishmanose cutanée contractée à Djibouti et résistante à l'antimoniate de méglumine. Bull Soc Pathol Exot 2003; 96:209-11.
15. Torre-Cisneros J, Prada J, Villanueva J et al. Successful treatment of antimony-resistant cutaneous leishmaniasis with liposomal amphotericin B. Clin Infect Dis 1994; 18:1024-5.
16. Wortmann G, Fraser S, Aronson N et al. Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis. Clin Infect Dis 1998; 26:1006-7.